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Alterations in the human gut microbiome have been impli-cated in a wide range of complex, chronic conditions, includ-ing inflammatory bowel disease (IBD), obesity, diabetes 
mellitus, cancer and cardiovascular disease1,2. There is an apprecia-
ble body of work on the metagenomic potential of faecal commu-
nities3–6, yet little information is available regarding transcriptional 
activity of the microbiome. The metatranscriptome represents a 
link between the metagenome and community phenotype, and 
surveying its molecular activity is important to understanding the 
functional ecology of the human gut microbiome.
Metatranscriptomics has most commonly been applied to 
ecological profiles of environmental microbial populations. For 
instance, deep sequencing of marine bacterioplankton RNA estab-
lished transcript inventories, uncovered gene expression trends 
among metabolic generalists and specialists, and identified patterns 
of substrate use and elemental cycling in the ocean ecosystem7. 
Early human faecal metatranscriptomics suggested subject-spe-
cific relationships between microbiome transcripts and gene copy 
number, differing across biological functions8. Our own pilot work 
with the cohort studied here introduced protocols for integrating 
metatranscriptomic sampling into large-scale epidemiological stud-
ies, demonstrating that metatranscriptional profiles are less vari-
able than faecal taxonomic profiles but more individualized than 
metagenomic function9.
However, previous studies have not surveyed the human faecal 
metatranscriptome at sufficient scale to identify areas in which it is 
uniquely informative relative to the underlying metagenome. It is 
not yet clear, for example, which human conditions are associated 
with specific microorganisms in the gut, versus their metagenomic 
functional profiles, versus metatranscriptomic activity10. Culture-
independent faecal microbial transcription has been used in only a 
few cases to date to identify causal mechanisms in health outcomes, 
such as strain-specific variation in Eggerthella lenta expression 
influencing the efficacy of cardiac therapy11. Integrated metagenom-
ics and metatranscriptomics have also been used in molecular diag-
nostics for cancer risk and transplant rejection12. Correspondingly, 
it remains to be determined what short-term or long-term health-
linked exposures can be assessed using faecal metagenomes or 
metatranscriptomes in prospective cohorts.
To address these gaps, we interrogated the human faecal metage-
nome and metatranscriptome in 929 and 372 samples, respectively, 
collected at up to four time points each from 308 healthy senior men 
participating in the Men’s Lifestyle Validation Study (MLVS), nested 
within the Health Professionals Follow-up Study (HPFS)13. This 
article provides an overview of the molecular biology and microbial 
ecology of these communities; a companion paper14 investigates the 
stability of features in such data for human population epidemiol-
ogy. We differentiated 'core' versus variably transcribed functions, 
assigned them to specific microorganisms, and assessed differences 
between subjects cross-sectionally and within subjects over time. 
Finally, ecological co-occurrence and strain diversity were assessed 
metagenomically, both remaining strikingly stable over time, and the 
latter comparing near-identically between this and an independent 
population from the Human Microbiome Project (HMP). Together, 
these findings therefore provide an in-depth large-scale exploration 
of the human faecal metatranscriptome in a species-specific context.
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The gut microbiome is intimately related to human health, but it is not yet known which functional activities are driven by 
specific microorganisms' ecological configurations or transcription. We report a large-scale investigation of 372 human faecal 
metatranscriptomes and 929 metagenomes from a subset of 308 men in the Health Professionals Follow-Up Study. We identi-
fied a metatranscriptomic 'core' universally transcribed over time and across participants, often by different microorganisms. 
In contrast to the housekeeping functions enriched in this core, a 'variable' metatranscriptome included specialized pathways 
that were differentially expressed both across participants and among microorganisms. Finally, longitudinal metagenomic pro-
files allowed ecological interaction network reconstruction, which remained stable over the six-month timespan, as did strain 
tracking within and between participants. These results provide an initial characterization of human faecal microbial ecology 
into core, subject-specific, microorganism-specific and temporally variable transcription, and they differentiate metagenomi-
cally versus metatranscriptomically informative aspects of the human faecal microbiome.
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Results
Meta’omic taxonomic and functional profiling. We generated tax-
onomic and functional profiles of 308 participants’ stool microbi-
ome samples at up to four time points each from DNA (n = 929) and 
RNA (n = 372) reads using MetaPhlAn2 (ref. 15) and HUMAnN2 
(ref. 16) (Fig.  1; Methods). From the DNA reads, a total of 468 
microbial species were detected, with individual samples contain-
ing 72 ± 13 (mean ± s.d.) species. HUMAnN2 identified 1,569,171 
unique UniRef90 gene families in metagenomes and 602,896 in 
metatranscriptomes (Supplementary Table 1). Overall, 75.3% of all 
DNA reads and 64.1% of all RNA reads were assignable to UniRef90 
gene families by HUMAnN2; of these, 54.8% and 58.1% UniRef90 
gene families possessed functional characterization, respectively, 
and 10.7% and 13.2% of characterized gene families were assignable 
to MetaCyc pathways17. Intriguingly, an average of 69% and 85.4% 
UniRef90 relative abundances for metagenomes and metatranscrip-
tomes, respectively, were attributable to gene families lacking bio-
chemical characterization. Stool sample collection, sequence data 
generation and quality control are described in Methods.
Prior to investigating the metatranscriptome, we compared the 
metagenome-based taxonomic profile of this older cohort to pre-
vious population studies (Supplementary Fig. 1), as the mean age 
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Fig. 1 | Metatranscriptomic and metagenomic taxonomic and functional profile of a prospective human cohort. a, Participants (n =  308) from the 
MLVS, embedded within the HPFS prospective cohort13, provided a target of four stool samples each. These stool samples were self-collected in 2 pairs, 
6 months apart, with each pair spanning 2–3 days. This yielded 929 total metagenomes and 372 metatranscriptomes, sequenced using previously 
published protocols9 and functionally profiled using HUMAnN2 (ref. 16). b, To estimate gene family, enzyme class and pathway relative transcription, 
RNA abundances were normalized to corresponding DNA abundances. We then evaluated 'core' (prevalently transcribed) and variable transcriptional 
elements, in addition to the ecological and phylogenetic diversity of metatranscription and carriage of functional elements among species. EC, Enzyme 
Commission number for enzymes. c, Taxonomic profiles were determined using MetaPhlAn2 (ref. 15) from both DNA and RNA data (for RNA viruses). 
These were also used for ecological interaction network reconstruction26 with BAnOCC45 (http://huttenhower.sph.harvard.edu/banocc) and for strain 
tracking with StrainPhlAn29.
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of our participants was 69 ± 6 years. As in earlier studies with com-
parable populations and protocols18,19, and in contrast to younger 
cohorts with different sample handling methodology3, Firmicutes 
were generally prevalent and abundant, in contrast to previous stud-
ies of comparable but smaller populations such as ELDERMET19,20 
(Supplementary Fig. 2). In addition, a small number of both DNA 
and RNA viruses were quantified confidently by MetaPhlAn2, 
which is probably an underestimate of the gut virome diversity, 
as our extraction protocol did not enrich for virus-like particles. 
Although gut viral ecology is more difficult to analyse than that 
of the bacteriome owing to inadequate viral reference sequences21, 
these methods allow for some incidental analysis of DNA phage 
and RNA plant viruses in human faecal metagenomes and meta-
transcriptomes (see Supplementary Information).
As a first indication of important differences between fae-
cal metagenomic and metatranscriptomic profiles, each sample’s 
metatranscriptome contained, on average, 5.4% of the total pool of 
gene families observed across the data set; metagenomes averaged 
> 10% of the pool (Supplementary Table 1). This indicates that, as 
in a single organism’s genome, only a subset of faecal functional 
potential is active under the circumstances captured by a typical 
sample. Technical factors had a minor role in this, as, although 
RNA was sequenced at slightly shallower depth (Supplementary 
Data set  1), rarefaction indicates that metagenomic taxa, func-
tions and metatranscriptomic functions were well saturated at these 
depths (Supplementary Fig. 3). Biological factors seemed to domi-
nate, as transcribed elements should typically be at most those also 
observed metagenomically. Ecologically, this is also in agreement 
with our previous observation that the metatranscriptome is more 
variable than the metagenome9.
Core and variable faecal metatranscriptomes differ from the 
metagenome. To identify important pathways expressed (and 
not just metagenomically encoded) by microorganisms in the 
human gut, we delineated 'core' and 'variable' portions of the fae-
cal metatranscriptome (Fig. 2, Supplementary Data sets 2 and 3). 
The former was defined as a set of prevalently transcribed path-
ways that was robust to sequencing depth and specific preva-
lence threshold (Supplementary Fig.  4). From 289 pathways 
with detectable transcription in at least two samples, 81 (28%) 
were core by this definition, 48 of which had a mean DNA-
normalized transcript abundance of > 1 when transcribed (see 
Methods for quantification of metatranscriptional activity). This 
was remarkably smaller than a similarly defined core metage-
nome in this cohort: from 407 pathways with detectable DNA 
in at least two samples, 182 (45%) were similarly prevalent, even 
though there were almost three-times more metagenomes than 
metatranscriptomes. It is noteworthy that neither GC content 
nor open reading frame (ORF) length had effects on transcrip-
tion ratios (see Supplementary Information and Supplementary 
Fig. 5). This suggests that gene expression rather than gene abun-
dance underlies qualitative and quantitative differences among 
metatranscriptomes.
Unlike the core metagenome, which includes various host-
adapted microbial community features3, the core metatranscrip-
tome was enriched mainly for housekeeping functions. Nineteen 
nucleotide biosynthesis pathways, 19 glycolysis and carbohydrate 
metabolism pathways and 15 amino acid biosynthesis pathways 
accounted for the majority of core metatranscribed pathways. Note 
that as annotated in MetaCyc, glycolysis represents an umbrella 
term that also includes anaerobic fermentation, not an indicator of 
aerobic respiration. Glycolysis in this sense had the highest tran-
script abundance (8.30 ± 5.69 (mean ± s.d.)) and, together with 
three nucleotide metabolism pathways, was over-transcribed (rela-
tive to DNA abundance) in virtually all metatranscriptome samples 
(Fig. 2a,b and Supplementary Fig. 6).
Other notable core metatranscriptome pathways included the 
non-oxidative pentose phosphate cycle (to support nucleic acid syn-
thesis), breakdown of carboxylates, synthesis of co-factors (folate, 
flavin, pantothenate and coeznyme A (CoA)), unsaturated fatty 
acids, and microbial recycling of uric acid (the end product of purine 
breakdown) to salvage nitrogen. Conversely, cell wall peptidoglycan 
and phospholipids, and amino acid synthesis were pathways with 
the lowest transcript abundance in the core metatranscriptome. 
Interestingly, the core metatranscriptome also included synthesis of 
preQ0 (prequeosine-0) and queosine, pleiotropic bacterial metabo-
lites22 that the human host salvages for regulating translational effi-
ciency and fidelity23.
In contrast to the limited core set of metatranscriptomic path-
ways, the variable metatranscriptome comprised 95 function-
ally diverse pathways that were well detected in DNA but below 
detection in at least half of RNA samples (Fig.  2c); 36 of these 
had no detectable RNA in more than two-thirds of the metatran-
scriptome samples. The bulk of these pathways are involved in 
biosynthesis of various amino acids, long fatty acids, terpenoids, 
polyamines, co-factors (NAD, haem and tetrapyrolle) and the (p)
ppGpp alarmone24. A smaller number are pathways involved in 
the degradation of various alcohols, sugars, formaldehyde and sul-
fate reduction. Finally, 26 pathways were below detection in most 
DNA (and matching RNA) samples. However, when transcribed, 
some of these pathways had the highest transcript abundance, for 
example, methanogenesis and factor 420 biosynthesis (Fig. 2d and 
Supplementary Fig. 6f), suggesting that metagenomically rare but 
overtranscribed pathways may be uniquely responsible for subject-
specific gut microbial bioactivity.
Faecal microbiome pathways are transcribed by a limited sub-
set of microorganisms encoding them metagenomically. Using 
paired metagenomic and metatranscriptomic functional profiles, we 
next assessed the relationship between faecal microorganisms that 
tend to carry pathways metagenomically versus those that express 
them metatranscriptomically (Fig.  3 and Supplementary Fig.  7). 
At a global level, these two aspects of functional diversity corre-
sponded (in large part as only microorganisms carrying a pathway 
can express it) with three main groups of pathways that dominate 
the functional diversity of these samples. First, housekeeping func-
tions (nucleotide, carbohydrate and amino acid metabolism, among 
others) were carried by almost all stool species (high contributional 
alpha diversity); they were also actively transcribed by abundant and 
prevalent microorganisms, predominantly Bacteroides, Eubacterium 
and Ruminococcus spp. (Fig. 3a, bottom cluster). A second pathway 
cluster (Fig.  3a, top left) with modest contributional alpha diver-
sity was dominated by Faecalibacterium prausnitzii, a particularly 
prevalent organism in this cohort that, when abundant, tended 
to contribute the majority of all pathways it encodes (synthesis of 
various amino acids, non-oxidative pentose phosphate pathway and 
putrescine synthesis, among other pathways). The third, low diver-
sity, cluster (Fig. 3a, top right) was encoded by limited numbers of 
opportunists, for example, Escherichia coli, Sutterella, Enterobacter 
and Enterococcus spp. This cluster included pathways such as syn-
thesis of the enterobactin siderophore, lipid A and sulfate reduction. 
Pyruvate fermentation to acetate and lactate, synthesis of glycogen 
and tetrapyrrole were examples of pathways with fairly even metage-
nomic and metatranscriptomic species contributions. Thus, in sum-
mary, the same microorganisms were principal contributors to RNA 
and DNA abundances in roughly one-third of pathways. However, 
for the majority of pathways, overtranscription was observed 
from members of either the Bacteroidetes (mainly for pathways 
contributing to active growth in the gut) or the Proteobacteria 
(for the subset of generalists pathways upregulated in faeces) rela-
tive to the baseline level of metagenomic carriage (for example, by 
the Firmicutes).
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These three major patterns in the functional structure of the 
faecal metatranscriptome are explained in greater detail by the 
pathways that are most commonly expressed by abundant micro-
organisms. First, all species shared enrichments for housekeeping 
functions (for example, nucleotide synthesis and fermentation, 
among others) (Fig. 3b, left columns). A set of anaerobic biosynthesis 
pathways were mainly expressed by Firmicutes from the upper left 
cluster of the ordination (Fig. 3b, middle columns). Transcription of 
cell structure, secondary metabolites and co-factor synthesis path-
ways was characteristic of Bacteroides spp. (Fig. 3b, right columns). 
Finally, the Enterobacteriaceae were not abundant in most subjects, 
so few of their pathways were prevalent enough to appear in those 
selected for visualization, but the subset of their large pangenome 
upregulated in faeces overlapped to a degree with the anaerobic 
metabolism expressed by the Firmicutes (Fig. 3b, middle columns).
Many pathways are transcribed by few organisms per commu-
nity, even when broadly encoded metagenomically. Finally, we 
noted that per-microorganism pathway expression is often very 
different among individual hosts than is metagenomic pathway car-
riage, indicating that these two molecular measurements may have 
distinct applications in human population studies (Fig. 4). Overall, 
metagenomic richness (the number of contributing species) gener-
ally exceeded metatranscriptomic richness, as expected. As above, a 
subset of pathways were both broadly encoded and expressed (high 
diversity), with relatively few differences between individuals, and 
these were again mainly housekeeping functions. However, at the 
other end of the spectrum, many pathways of greater biochemical 
interest were transcribed by only one or a few species, even when 
diversely carried metagenomically. An extreme example of low 
transcriptional diversity pathways was methanogenesis, encoded 
and transcribed solely by Methanobrevibacter smithii; this class of 
metatranscriptomic functions may indicate keystone processes and 
their associated microorganisms in the gut.
To better understand this phenomenon, and to expand on 
our previous observation of basal transcription in a substantial 
fraction of gut pathways9, we next identified pathways for which 
the transcriptional activities of microorganisms mirrored their 
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metagenomic carriage (Fig.  4b). For this, we used the weighted 
mean of the Spearman correlation between taxonomically strati-
fied metagenomic and metatranscriptomic profiles (see Methods). 
To emphasize the correlation of the principal species encoding 
each pathway, correlation coefficients were weighted by the mean 
metagenomic potential of the species. High values indicated that 
species-level RNA abundances closely follow DNA abundances, 
whereas low values indicated departure from basal expression. 
In general, carbohydrate metabolism and nucleotide biosynthesis 
particularly tended to be enriched for high correlations, whereas 
amino acid biosynthesis was enriched among low correlations. 
Low correlations indicate more context-specific, variable expres-
sion of the pathway, consistent with the generally amino-acid-rich 
environment of the gut. Co-factor biosynthesis pathways were 
roughly in the middle of this range, perhaps due to the diversity 
of compounds produced with these functions and their variable 
availability in the gut. For example, pantothenate is found in most 
foods and is easily salvaged from the gut environment, whereas 
folate transformations are critical for one-carbon (C1) metabo-
lism25, making this pathway more widely transcribed when present 
in species.
Notably, pathways with similar metagenomic contributions were 
not necessarily similarly transcribed (Fig. 4c,d). Core pathways were 
both metagenomically and metatranscriptomically diverse, carried 
and expressed by many organisms per community (Fig.  4d and 
Supplementary Fig.  8). However, typical variable pathways, even 
when broadly distributed metagenomically, were often transcribed 
by one or few organisms per individual. Transcribing organisms 
were often neither the most abundant nor the same species across 
individuals (Fig. 4c). Similar patterns were observed for l-isoleucine 
biosynthesis III (PWY-5103), l-tryptophan biosynthesis (TRPSYN-
PWY), degradation of various sugars (stachyose (PWY-6527), 
sucrose (PWY-621), rhamnose (RHAMCAT− PWY)), non-oxida-
tive pentose phosphate pathway, preQ0 biosynthesis (PWY− 6703), 
and others (Supplementary Fig. 8). This finding highlights another 
aspect of inter-individual diversity in the microbiome: different 
microorganisms may activate shared pathways among individuals, 
with as-yet-unknown functional specializations and consequences.
Inter-microbial species interactions are stable in the stool eco-
system of older men. To leverage this cohort’s taxonomic pro-
files independently of their metatranscriptomes, we also inferred 
metagenomic microbial interaction networks26 using the Bayesian 
Analysis of Compositional Covariance (BAnOCC) framework (see 
Methods; Fig. 5 and Supplementary Fig. 9). We generated one net-
work per time point, allowing the stability of co-occurrence and 
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co-exclusion relationships to be determined. Negative associations 
between Bacteroides spp. and Ruminococcaceae or Prevotellaceae 
observed previously26 were not recapitulated in this population, and 
Firmicutes species predominantly co-occurred with other mem-
bers of the phylum. This is consistent with the observation that co-
occurrence/co-exclusion among microbial community members 
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Fig. 4 | Transcriptional landscape of the stool microbiome. a, Distributions of alpha diversity (Gini–Simpson index) for the species-specific metagenomic 
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across 341 metatranscriptomes from 96 participants. Pathways were sorted by the sum of the median metagenomic alpha diversity and the weighted 
Spearman correlation from b. Boxplot whiskers represent 1.5 times the interquartile range from the first and third quartiles. b, Concordance of metagenomic 
potential with metatranscriptomic activity (metagenome-weighted mean of per-species Spearman correlations; see Methods). Metatranscriptomic 
diversity is, as expected, consistently lower than metagenomes, with pathways carried by only a few organisms that are also more differentially transcribed; 
dns, deoxyribonucleosides. See caption of Fig. 3 for definitions. c,d, Metagenomic potential (bottom) and metatranscriptomic activity (top), for example, 
contribute pathways with differing ecological structure, specifically GDP-mannose biosynthesis (PWY-5659) (c) and adenosine ribonucleotide de novo 
biosynthesis (PWY-7219) (d). Abundances were normalized within each pathway for 189 subject–week pairs, from 96 participants. Subjects (columns) were 
ordered to emphasize blocks of subjects with similar metatranscriptomic profiles (see Methods). The top 8 (c) and top 15 (d) species, in terms of their 
mean metatranscriptomic contribution to the pathways in c and d, are shown for clarity. Examples show transcriptional ecologies that either differ strikingly 
from c or generally mirror d in their metagenomic diversity. Pathway definitions on the x axis of panel b were truncated for space; full definitions can be 
found in Supplementary Data sets 2 and 3, as well as on www.metacyc.org by searching for pathway names, for example PWY-7219.
NATuRE MICRoBIoLoGy | VOL 3 | MARCH 2018 | 356–366 | www.nature.com/naturemicrobiology 361
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. © 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Articles NaTUre MIcrobIology
is not based solely on phylogenetic relatedness, but also on how 
microorganisms complement each other functionally27.
Genetic divergence patterns of stool-associated bacterial strains 
are species-specific and preserved among host populations. 
Finally, we assessed strain-level variation in stool bacterial popula-
tions using StrainPhlAn (see Methods) and provided a comparison 
of species population structure between the MLVS and the HMP3,28 
cohorts (Fig.  6). Twenty-one species had sufficient genomic cov-
erage for reliable strain identification from metagenomes in both 
cohorts. Eubacterium siraeum, for example, demonstrated discrete 
strain clustering indicative of a clonal population, with strains from 
the same individual remaining near-identical over the sampling 
period. Conversely, nucleotide variation among F. prausnitzii strains 
did not reveal a discernible pattern, and was characterized by the 
highest median and widest range of nucleotide substitution rates, 
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Fig. 5 | Ecological interactions in the gut microbiome. Significant co-variation and co-exclusion relationships among 104 species in 913 stool 
metagenomes from 307 MLVS participants. Each node represents a species and edges correspond to significant interactions inferred by BAnOCC (see 
Methods). Stool microbiome taxonomic profiles were averaged within each subject for the first and second collection pairs (separated by 6 months). 
Interactions in at least one time point are included here. No alternating associations (positive at one time and negative in another) were detected. 
Ninety-five per cent credible interval criteria were used to assess significance and only estimated absolute correlations with effect sizes of ≥ 0.15 are 
reported. Networks for individual time points are shown in Supplementary Fig. 9. Complete taxonomic profiles for all stool metagenomes can be found in 
Supplementary Table  3.
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consistent with extreme genomic diversity whereby each strain can 
be substantially distinct from another. Several species, including 
Bacteroides stercoris, Bacteroides uniformis and Butyrivibrio crosso-
tus, presented an intermediate structure with weak clonal propaga-
tion of a potential outgroup (Supplementary Fig. 10).
Remarkably, nucleotide substitution rates were near-identical 
between the two unrelated cohorts (Fig. 6c). The average ratio of 
between-cohort to within-microorganism divergence was 1.0 ± 0.03 
(mean ± s.d.), indicating that bacterial population structure is con-
sistent across host populations. Previous studies have shown that 
human gut microorganisms can diverge between geographically 
and genetically distinct host populations29. However, the existence 
of such closely related microbial strains between independent 
North American cohorts with very different age ranges (18–40 
versus 65–81 yr) suggests that specific microbial strains (or related 
strain groups) may be a useful, stable feature to assay during epide-
miological studies.
Discussion
The present study has provided an overview of the faecal metatran-
scriptome in a prospective, large-scale cohort of elderly males; iden-
tified core and variably transcribed pathways; delineated how these 
differ from metagenomic functional potential; and ascribed them 
to specific contributing organisms. Finally, paired metagenomes in 
this study also allowed species-specific ecological interaction net-
works to be reconstructed, which proved stable over time, as did 
strain tracking within species. This stability, in combination with 
the commonality of strain-level microbial population structures 
between cohorts, suggests that they might represent particularly 
effective measurement targets for the microbiome in population 
studies. Together, these findings extend our earlier pilot study in 
eight individuals9 and accompany epidemiological work14 to inte-
grate metatranscriptomics into population studies.
It is evident from our results that the metatranscriptome is more 
temporally dynamic, context-sensitive and species-specific than 
the metagenome. The observed incongruence between species 
abundance and transcriptional activity agrees with an earlier study 
of taxa–function relationships in the human faecal metatranscrip-
tome30. This is expected, as transcription is a highly variable process 
even among cells of the same species under steady-state condi-
tions31. However, heterogeneity among species’ transcriptional con-
tributions in otherwise similar metagenomes may be influenced by 
many factors, including nutrient availability, preferential utilization 
or xenobiotics; temporal differences in environmental sensing that 
stagger response to stimuli among species; and metabolic depen-
dence that drives cross-feeding of intermediate metabolites through 
community members32,33. This extends the typical model of tran-
scriptional behaviour from individual microbial or metazoan cell 
populations to niche ecology.
A feature of the metatranscriptome, which is critical for human 
microbiome population studies, was the propensity of different 
organisms to appear as primary transcribers of pathways between 
individuals. In relating metagenomic features to the metatranscrip-
tome, we observed only 44% of the 'core' metagenomic potential 
(81 transcribed pathways out of 182 prevalent metagenomically) to 
be transcribed in the cohort. In combination with previous stud-
ies of 'core' metagenomics18,34,35, this suggests a functional ecologi-
cal model in which a prevalent metagenome encoding substantial 
redundancy is distributed among many microorganisms per indi-
vidual, with the microorganisms containing this core varying 
among hosts. Transcription at any one time or in any given environ-
ment is then typically dominated by one or a few members. This 
model of microbial ecology would be analogous to silencing versus 
upregulation of distinct portions of the human genome among cell 
types, which also consists of a 'core' underlying DNA genome with 
long-term (epigenetics, instead of phylogeny) and short-term (tran-
scriptional) regulatory mechanisms36.
In addition to these insights into metatranscriptional activity, 
stool taxonomic profiles in the MLVS cohort remained diverse and 
stable, which is in agreement with previous studies of the microbi-
ome in elderly individuals20. However, few profiles of this unique 
ecosystem have yet been generated, and those that do exist tend to 
use widely varied technical characteristics and study design, pro-
hibiting direct comparisons. ELDERMET37, for example, posited 
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boxplots for each species. Lines represent median values, points denote outliers outside 1.5 times the interquartile range. All numbers in parentheses 
are sample counts in which indicated strains were above the limit of detection, from a total of 913 MLVS stool metagenomes and 553 HMP stool 
metagenomes (from 253 male and female HMP participants) that were analysed with StrainPhlAn. SNPs, single-nucleotide polymorphisms.
NATuRE MICRoBIoLoGy | VOL 3 | MARCH 2018 | 356–366 | www.nature.com/naturemicrobiology 363
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. © 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Articles NaTUre MIcrobIology
a trend towards Bacteroidetes dominance in ageing, but this rep-
licated neither across technologies within this cohort nor in our 
MLVS data. As MLVS data are drawn from within the broader 
HPFS, for which several decades of dietary and environmental 
data are available, we anticipate that future studies focusing on 
these detailed metadata will further detail microbial links to life-
style and nutrition.
A challenge going forward will thus be to identify epidemiologi-
cal contexts in which metatranscriptomic features are specifically 
informative, and the appropriate ways in which to measure them. 
This might include, for example, tests for health outcomes that are 
predicted uniquely by metagenomic activities. These may, based on 
this study’s results, be functionally consistent but contributed by 
different microorganisms across individuals, even when not differ-
entially represented in underlying metagenomes. It also remains to 
associate metatranscriptomic responses with detailed information 
on immediate lifestyle exposures, such as recent diet, to determine 
temporal responses of the metatranscriptome to key environmen-
tal perturbations. Ultimately, if there are health outcomes for which 
causal molecular mechanisms are uniquely detectable in the faecal 
metatranscriptome, its functional profile will need to be better char-
acterized and integrated as a measurement in human epidemiologi-
cal population studies.
Methods
MLVS cohort, stool sample collection, shotgun sequencing and quality 
control. The HPFS is a prospective cohort study aimed at investigating the 
determinants of men’s health, into which 51,529 US men aged 40–75 yr were 
recruited in 1986 and subsequently followed biennially13. For this analysis, we 
used data from a sub-study of the HPFS, the MLVS, in which 308 participants 
provided up to two pairs each of self-collected stool samples from consecutive 
bowel movements, during 2012. The second pair of samples was collected 
approximately 6 months after the first. The median time between consecutive 
bowel movements for a pair of samples was 48 h; collection dates are in 
Supplementary Table 2. At the time of collection, the age of participants ranged 
between 65 and 81 yr. Cohort details, sample collection and immediate ex situ 
conservation of metagenomic and metatranscriptomic components, laboratory 
handling, and paired-end (100 × 100 nucleotides (nt)) shotgun sequencing of 
RNA and DNA are detailed in the companion manuscript14 and in our pilot 
study9, respectively. Study protocol 22067–102 titled “Men’s Lifestyle Validation 
Study and Microbiome Correlation” was approved by the Harvard Chan School 
of Public Health Institutional Review Board, and informed consent was obtained 
from all participants.
The gut microbiome, as captured by stool, was sampled from 308 male 
participants (aged 65–81 yr) within the MLVS sub-cohort of the HPFS (Fig. 1). 
Each participant provided up to two pairs of self-collected stool samples from 
consecutive bowel movements; with the second pair of samples collected 
approximately 6 months after the first. DNA was extracted from all 929 
resulting samples, in addition to RNA from a subset of 372 samples spanning 96 
participants. Illumina HiSeq sequencing yielded a total of 4.5 Tera nt of paired-end 
reads (100 × 100 nt). This included an average of 3.8 Gnt ± 1.5 Gnt (mean ± s.d. 
Giga nt) before quality filtering (see below) and 1.9 Gnt ± 0.7 Gnt afterward per 
metagenome, and 3.0 Gnt ± 2.4 Gnt and 1.3 Gnt ± 1.0 Gnt before and after quality 
control for metatranscriptomes, respectively. Forty-one samples (16 DNA and  
25 RNA) had < 1 million reads after quality filtering and were excluded from 
further analysis. Thus, the final data sets analysed comprised 913 metagenomes 
and 347 metatranscriptomes.
Taxonomic and functional profiling of metagenomic and metatranscriptomic 
samples. Sequence reads were passed through the KneadData v0.3 quality control 
pipeline (http://huttenhower.sph.harvard.edu/kneaddata), which incorporates 
the Trimmomatic38 and BMTagger39 filtering and decontamination algorithms 
to remove low-quality read bases (thresholding Phred quality score at < 20) 
and remove reads of human origin, respectively. Trimmed non-human reads 
shorter than 70 nt were discarded. Taxonomic profiling was performed using the 
MetaPhlAn2 classifier15, which relies on approximately 1 million clade-specific 
marker genes derived from 17,000 microbial genomes (corresponding to  
> 7,500 bacterial, viral, archaeal and eukaryotic species) to unambiguously classify  
metagenomic reads to taxonomies and yield relative abundances of taxa identified 
in the sample. We quality-controlled taxonomic profiles by requiring at least 10% 
of clade-specific markers to recruit at least 1 read per kilobase (RPK) for inclusion 
in subsequent analyses. In addition to DNA, RNA (complementary DNA (cDNA)) 
reads were also analysed with MetaPhlAn2 to quantify RNA viruses.
Metagenomes and metatranscriptomes were functionally profiled using 
HUMAnN2 (ref. 16) to quantify genes and pathways (http://huttenhower.
sph.harvard.edu/humann2). Briefly, for each sample, taxonomic profiling is 
used to identify detectable organisms. Reads are recruited to sample-specific 
pangenomes, including all gene families in any detected microorganisms using 
Bowtie2 (ref. 40). Unmapped reads are aligned against UniRef90 (ref. 41)  
using DIAMOND translated search42. Hits are counted per gene family and 
normalized for length and alignment quality. For calculating abundances 
from reads that map to more than one reference sequence, search hits are 
weighted by significance (alignment quality, gene length and gene coverage). 
UniRef90 abundances from both the nucleotide and protein levels were then 
(1) mapped to level 4 EC nomenclature, and (2) combined into structured 
pathways from MetaCyc17. We used the MinPath43 and gap filling options in 
HUMAnN2 version 0.8.0. For the purposes of functional profiling, each read 
can be (1) mapped to a specific organism’s characterized gene family in one or 
more known pathways, (2) mapped to a characterized protein family (without 
assignment to a specific organism), (3) mapped to an uncharacterized gene 
family (not in any pathway), or (4) not mapped to any gene family. HUMAnN2 
refers to these as (1) species-specific, (2) unclassified, (3) unintegrated, and (4) 
unmapped reads, respectively. Per sample breakdown of HUMAnN2 mapping 
categories (that is, mapped, unclassified, unintegrated and unmapped RPKs) 
are provided in Supplementary Data set 5. Reads that mapped only at the amino 
acid level are not used when calculating specific taxa’s functional contributions. 
Instead, only reads that mapped (unambiguously) at the nucleotide level are 
included in these totals.
Quantification of metatranscriptomic functional activity. Metatranscriptomic 
functional activity was assessed in the 341 samples with both RNA and DNA 
data in a manner not unlike two-channel microarrays using RNA/DNA 
ratios (see RNA/DNA normalization below). Owing to the compositionality 
of RNA and DNA measurements, the resulting ratio is relative to the mean 
transcript abundance of the entire microbial community. That is, a ratio of 1 
implies that the pathway is transcribed at the mean transcription abundance 
of all pathways in the microbial community. These quotients of RNA/DNA 
feature abundances allowed unbiased comparison of transcript abundances of 
metagenomic features between samples and also provided a comparative index 
of over/undertranscription (relative to DNA copy number) within individual 
microbiome samples. Pathways that had < 1 RPK of either RNA or DNA were 
treated as not detected in the analyses.
RNA/DNA normalization. Metatranscriptomic features (that is, RNA abundances 
of genes, enzymes and pathways) were normalized to corresponding metagenomic 
features to obtain an estimate of the mean transcription abundance λ as follows:
∑
∑
λ =
−
×
−
( )
( )
R H R t
R
D
D H D tf i
f i f i
i f i
i f i
f i f i
,
, ,
,
,
, ,
Rf,i and Df,i are the counts, in RPK, of feature f in sample i, for the 
metatranscriptome and metagenome respectively. H(x) is a unit step function 
with threshold x, and t is the detection threshold, here set to 1 RPK. This 
threshold ensures that RNA and DNA abundances that are confidently quantified 
(> 1 RPK) are included, reducing the effect of increased noise due to genes and 
transcripts with low sequencing coverage. Summary statistics and analyses were 
only performed where both the numerator and denominator are measurable, 
although such gene families were tracked in RNA or DNA alone, respectively. 
Note that a value λf,i = 1 does not imply that the feature has an equal number of 
copies in RNA as it does in DNA. Rather, it implies that the mean transcription 
abundance is equal to the global mean transcription abundance of all organisms 
in the community in sample i. Thus, λf,i > 1 implies a transcript abundance above 
the community mean, which may be different in different samples.
EC dispersion. Co-expression of functionally related ECs was quantified by the 
mean variance of the standardized EC expression log-ratios for the set of ECs 
contributing to a given pathway. Specifically:
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where xc,i is the expression log-ratio for EC c in sample i, P is a given pathway, 〈 • 〉  
represents the mean, and Var[● ] represents the variance. When the expression 
of functionally related ECs is not related (that is, uncorrelated), then this value is 
expected to be 1. Lower values indicate the presence of co-expression of ECs, with 0 
indicating a perfect relationship.
Species-specific meta’omic concordance. Concordance between species-level 
metagenomic and metatranscriptomic pathway abundances was assessed using 
the mean of the Spearman correlation, weighted by the mean metagenomic 
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contribution of each species to the overall pathway abundance. After averaging 
across multiple samples per subject, we calculated:
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where dp,s,i and rp,s,i are the relative abundances of pathway p, contributed by 
species s in sample i in DNA and RNA, respectively. Spearman is the Spearman 
correlation between two vectors, where ties are given the mean rank of the tied 
values, and defined to be 0 when either vector has no variance. This weighting 
downweights the concordance for species that do not contribute much of the 
pathway’s abundance, mitigating the uncertainty inherent in estimating transcript 
abundances of low-abundance species and genes.
Microbial ecology networks. Ecological covariation was assessed using BAnOCC, 
a Bayesian model for detecting significant pairwise associations in compositional 
data26 (http://huttenhower.sph.harvard.edu/banocc). Briefly, BAnOCC models 
the sequence generation process using a log-normal distribution on unobserved 
absolute counts, and constrains the associated correlation matrix through a 
sparsity-inducing prior. For posterior inference, we use the 95% credible interval, 
that is, a correlation estimate is considered significant if the corresponding 
95% credible interval excludes zero. We estimated ecological networks for the 
two sampling time points independently, from within-subject means of species 
abundance profiles, and then overlaid the networks to assess similarities and 
differences between networks over the length of the sampling period.
Inference of strain-level population structure. Strain profiling was carried out 
using StrainPhlAn v1.0 (ref. 29) (http://segatalab.cibio.unitn.it/tools/strainphlan). 
Briefly, after mapping reads to MetaPhlAn2 species-specific markers for 
sufficiently abundant species in each sample, a per-sample consensus sequence 
is built for each marker. For each species, these are concatenated, aligned, and 
variants identified relative to reference. Here, pairwise evolutionary distances 
were calculated from these variant alignments, with the Kimura two-parameter 
distance44 for ordination analysis using R packages vegan and ggplot2.
Structure of the stool metagenome and metatranscriptome as contributed by 
diverse species. The input for the joint ordination of pathways and species (Fig. 3a) 
was the pathway genomic and transcriptional abundance of known taxonomic 
provenance only, averaged over 913 metagenomes and 341 metatranscriptomes. 
Species contributing < 1.0 ⨯ 10–7 metagenomic relative abundance to a pathway 
in < 5% of pathways were removed, and the same criteria were used to remove 
metagenomic pathways found in species. Out of 339 species that were found to 
contribute to 219 pathways, 223 (65.8%) species and 109 (34.2%) pathways satisfied 
the filtering criteria. The metatranscriptome pathway by species matrix was subset to 
the same 109 pathways as for metagenomes, which were contributed by 194 species, 
and merged with the DNA pathway by species matrices into a single input matrix.
Life Sciences Reporting Summary. Further information on experimental design is 
available in the Life Sciences Reporting Summary.
Data availability. Sequence data have been deposited in the Sequence Read 
Archive under BioProject accession PRJNA354235. Data from the HPFS, including 
metadata not included in the current manuscript but collected as part of the MLVS, 
can be obtained through written application. As per standard controlled access 
procedure, applications to use HPFS resources will be reviewed by our External 
Collaborators Committee for scientific aims, evaluation of the fit of the data for the 
proposed methodology, and verification that the proposed use meets the guidelines 
of the Ethics and Governance Framework and the consent that was provided by the 
participants. Investigators wishing to use the HFPS/MLVS cohort data are asked 
to submit a brief (2 pages) description of the proposed project ('letter of intent') to 
Eric Rimm, HPFS Director (erimm@hsph.harvard.edu).
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?    Experimental design
1.   Sample size
Describe how sample size was determined. The cohort was pre-existing, detailed in citation 13{PMID:18005960} of the 
manuscript.   
The Health Professionals Follow-up Study (HPFS) is an ongoing prospective cohort 
study which began in 1986 among 51,529 US male podiatrists, dentists, 
osteopathic physicians, veterinarians, pharmacists, and optometrists aged 40 to 75 
years at enrollment. In this study, participants have returned questionnaires every 
two to four years with greater than 90% follow-up to provide information about 
lifestyle and dietary factors, medication use, and diagnoses of colorectal cancer 
and other diseases. The Men’s Lifestyle Validation Study (MLVS) was established 
among 700 men aged 52 to 81 years (median 69 years) nested within HPFS who 
had completed the 2010 food frequency questionnaire and previously provided a 
blood sample. 
2.   Data exclusions
Describe any data exclusions. Men with coronary artery disease, stroke/TIA, cancer (except squamous or basal 
cell skin cancer), or major neurological disease (ALS, Alzheimer’s, Parkinson’s, 
epilepsy, MS) were excluded. 
Sequencing data was excluded if samples had insufficient input material after DNA/
RNA extraction or with insufficient sequencing depth (<2 million reads) after 
sequencing.
3.   Replication
Describe whether the experimental findings were 
reliably reproduced.
Sample collection and data generation was validated in a previous study (Franzosa 
et al., Relating the metatranscriptome and metagenome of the human gut, PNAS 
2014). All code for the taxonomic and functional analysis has been validated and is 
publicly available (see Methods section for details).
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
Patients were consented prior to a screening colonoscopy, which separated them 
into confirmed IBD patients and non-IBD controls.
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
Blinding was not used for the data collection and analysis.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more 
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
?   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
Sequence reads were processed with the KneadData v0.5.1 quality control (QC) 
pipeline. Taxonomic profiling was performed using the MetaPhlAn2 classifier. 
Functional profiling of metagenomes and metatranscriptomes was performed 
using HUMAnN2. Details are provided in the methods section of the manuscript.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
?   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a for-profit company.
No unique materials were used.
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
Not applicable. 
10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. Not applicable. 
b.  Describe the method of cell line authentication used. Not applicable. 
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
Not applicable. 
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
Not applicable. 
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?    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide details on animals and/or animal-derived 
materials used in the study.
No research animals were used in this study.
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
The Men’s Lifestyle Validation Study (MLVS) was established among 700 men aged 
52 to 81 years (median 69 years) nested within HPFS who had completed the 2010 
food frequency questionnaire and previously provided a blood sample. 
